These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8724830)

  • 21. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease.
    Kilwinski J; Berger T; Mpalaskas J; Reuter S; Flick W; Kern P
    Clin Exp Immunol; 1999 Jan; 115(1):114-9. PubMed ID: 9933429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity.
    De Carli M; D'Elios MM; Zancuoghi G; Romagnani S; Del Prete G
    Autoimmunity; 1994; 18(4):301-8. PubMed ID: 7858116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition.
    Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M; Pizzolo G
    Eur J Immunol; 1996 Feb; 26(2):329-34. PubMed ID: 8617299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines.
    Del Prete G; De Carli M; Almerigogna F; Daniel CK; D'Elios MM; Zancuoghi G; Vinante F; Pizzolo G; Romagnani S
    FASEB J; 1995 Jan; 9(1):81-6. PubMed ID: 7821763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD30 expression does not discriminate between human Th1- and Th2-type T cells.
    Hamann D; Hilkens CM; Grogan JL; Lens SM; Kapsenberg ML; Yazdanbakhsh M; van Lier RA
    J Immunol; 1996 Feb; 156(4):1387-91. PubMed ID: 8568238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-expression of CD30 ligand and interleukin 4 (IL-4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL-4-producing CD30+ normal T cells.
    Rossi FM; Degan M; Mazzocco FT; Di Francia R; Aldinucci D; Poletto D; Vellenga E; Pinto A; Gattei V
    Br J Haematol; 2002 Apr; 117(1):59-69. PubMed ID: 11918534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV can induce a TH1 to TH0 shift, and preferentially replicates in CD4+ T-cell clones producing TH2-type cytokines.
    Romagnani S; Maggi E; Del Prete G
    Res Immunol; 1994; 145(8-9):611-7; discussion 617-8. PubMed ID: 7754209
    [No Abstract]   [Full Text] [Related]  

  • 28. Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation.
    Bengtsson A; Johansson C; Linder MT; Halldén G; van der Ploeg I; Scheynius A
    J Leukoc Biol; 1995 Dec; 58(6):683-9. PubMed ID: 7499966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Th1 versus Th2 responses in AIDS.
    Romagnani S; Maggi E
    Curr Opin Immunol; 1994 Aug; 6(4):616-22. PubMed ID: 7946051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A role for T-helper type 1 and type 2 cytokines in the pathogenesis of various human diseases].
    Kasakura S
    Rinsho Byori; 1998 Sep; 46(9):915-21. PubMed ID: 9800477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role for CD30 in HIV expression.
    Romagnani S; Annunziato F; Manetti R; Almerigogna F; Biagiotti R; Giudizi MG; Ravina A; Giannò V; Tomasévic L; Maggi E
    Immunol Lett; 1996 Jun; 51(1-2):83-8. PubMed ID: 8811349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells.
    D'Elios MM; Romagnani P; Scaletti C; Annunziato F; Manghetti M; Mavilia C; Parronchi P; Pupilli C; Pizzolo G; Maggi E; Del Prete GF; Romagnani S
    J Leukoc Biol; 1997 May; 61(5):539-44. PubMed ID: 9129201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell subsets (Th1 versus Th2).
    Romagnani S
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):9-18; quiz 18, 21. PubMed ID: 10923599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis.
    Yamamoto J; Adachi Y; Onoue Y; Kanegane H; Miyawaki T; Toyoda M; Seki T; Morohashi M
    Allergy; 2000 Nov; 55(11):1011-8. PubMed ID: 11097309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotransmitter signalling via NMDA receptors leads to decreased T helper type 1-like and enhanced T helper type 2-like immune balance in humans.
    Orihara K; Odemuyiwa SO; Stefura WP; Ilarraza R; HayGlass KT; Moqbel R
    Immunology; 2018 Mar; 153(3):368-379. PubMed ID: 28940416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients.
    Woitas RP; Rockstroh JK; Beier I; Jung G; Kochan B; Matz B; Brackmann HH; Sauerbruch T; Spengler U
    AIDS; 1999 Jul; 13(11):1313-22. PubMed ID: 10449283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An alternative view of the Th1/Th2 switch hypothesis in HIV infection.
    Romagnani S; Maggi E; Del Prete G
    AIDS Res Hum Retroviruses; 1994 May; 10(5):iii-ix. PubMed ID: 7917511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.
    Becker Y
    Virus Genes; 2006 Oct; 33(2):235-52. PubMed ID: 16972040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergen-induced CD30 expression on T cells of atopic asthmatics.
    Leonard C; Tormey V; Faul J; Burke CM; Poulter LW
    Clin Exp Allergy; 1997 Jul; 27(7):780-6. PubMed ID: 9249270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulator and effector functions of T-cell subsets in human Leishmania infections.
    Kemp M
    APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.